Back to search
Università degli Studi di Torino
EPIGENETIC THERAPY FOR FRIEDREICH’S ATAXIA: A PHASE 1, FIRST IN MAN, ASCENDING DOSE CROSSOVER STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RG2833 (A HISTONE DEACETYLASE INHIBITOR) IN ADULTS WITH FRIEDREICH’S ATAXIA
Degree
thesis:*- Grantor dc:publisher
- Università degli Studi di Torino
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Clerico, Marinella
- De Mercanti, Stefania Federica
Subjects
dc:subject × 1Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- https://hdl.handle.net/2318/1995248
- OAI identifier oai:identifier
- oai:iris.unito.it:2318/1995248